Will CMS Find Aducanumab Reasonable and Necessary for Alzheimer Disease After FDA Approval?

Journal Article (Academic article)

Full Text

Duke Authors

Cited Authors

  • Richman, B; Schulman, K; Greicius, M

Published Date

  • 2021

Published In

  • Jama

PubMed ID

  • 29625496